whether Lantus increases cancer risk

We are working on the following article about Lantus and cancer. It is being considered by our Peer-Review panel, Specialty Consultants, and our Panel that refines the final recommendations. It is posted here now to give you a preview of what we may publish in a few days when it is final. If you have comments or suggestions on this draft article, please tell us right away.

Patients are asking whether Lantus increases cancer risk.

This comes from some recent European studies that show a higher cancer risk in patients using Lantus (insulin glargine) compared to other insulins.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote